Benjamin Wisniewski, MD

Publications

• Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J. 2022 Oct 20. [Epub ahead of print] PubMed PMID: 36265882
• Wisniewski BL, Witt RM, Cole MC, Gurbani, Huang G, Hossain M, Simakajornboon N. Maintenance of wakefulness test characteristics in pediatric populations with central hypersomnia. Oral session presented at: 35th Annual Meeting of the Associated Professional Sleep Societies: Sleep 2022. 2022 June; Charlotte, NC.
• Wisniewski BL, Witt RM, Dye TJ, Arya R, Simakajornboon N. A pediatric case of myoclonic seizures precipitating central sleep apnea and sequences of periodic breathing sequences during sleep. Poster session presented at: 35th Annual Meeting of the Associated Professional Sleep Societies: Sleep 2022. 2022 June; Charlotte, NC.
• Witt RM, Wisniewski BL, Cole MC, Gurbani N, Huang G, Hossain M Simakajornboon N. Utility of the urine drug screen in maintenance of wakefulness testing interpretation – a single-center retrospective analysis in pediatric patients. Oral session presented at: 35th Annual Meeting of the Associated Professional Sleep Societies: Sleep 2022; 2022 June; Charlotte, NC.
• Wisniewski BL & Hjelm MA. When the allergist and otolaryngologist diagnose cystic fibrosis: mucopurulent rhinitis and nasal polyposis in an obese adolescent with suspected cystic fibrosis. Oral presentation at: North American Cystic Fibrosis Conference 2022. 2022 November; Philadelphia, PA.
• Wisniewski BL, Swegheimer K, Boat TF, Hjelm MA. Sleep disturbance and school engagement in children with cystic fibrosis during the COVID-19 pandemic. Poster presentation at: North American Cystic Fibrosis Conference 2022. 2022 November; Philadelphia, PA.
• Wisniewski BL, Aylward SC, Jordan CO, Kopp BT, Paul GR. Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor/Tezacaftor/Ivacaftor initiation in a preadolescent with cystic fibrosis. J Cyst Fibros. 2022 May;21(3):e217-e220. PubMed PMID: 35131172
• Enzer KG, Baker CD, Wisniewski BL. "Bronchopulmonary Dysplasia" Clin Chest Med. 2023. In Press.
• Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J. 2023 Apr;61(4). PubMed PMID: 36265882

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234